Brand tirzepatide
Sold by Elevate Health · every brand tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$1,289
| Medication · Zepbound (Tirzepatide) Program — Monthly Subscription | $1,289 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Zepbound (Tirzepatide) Program — Monthly Subscription “Monthly Subscription $1289/monthly” | Per month$1,289 | Charged today$1,289 |
We earn nothing from this link. Elevate Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | “There are no long-term contracts. You can cancel anytime.” |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from joinelevate.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Prices came from the checkout/product pages linked off the homepage's treatment cards, not the homepage itself. Footer discloses the compounded products are 'not generic versions of, or the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®' confirming compounded classification for the GLP-1/GLP-GIP lines; a separate, much pricier checkout page sells the actual brand Zepbound at $1289/month. Homepage links carry an 'NYNM200' coupon query string; these prices were read without that parameter, so they represent the checkout's base default, not a state-specific discounted rate.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.